BIOCYTOGEN-B
0231550.1504.13% ( +1.990 )
BIOCYTOGEN-B (02315)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical...
- Open
- 48.160
- High
- 54.500
- Low
- 47.880
- Prev. Close
- 48.160
- Volume
- 2.01M
- Turnover
- 101.85M
- Avg Price
- 50.786
- Bid/Ask Ratio
- 66.67%
- Amplitude
- 13.75%
- 52wk High
- 70.150
- Volume Ratio
- 0.70
- Turnover Ratio
- 1.81%
BIOCYTOGEN-B Analyst Rating
View MoreForecast & Rating
Jul 4, 2026Price forecast
HK$62.0323.69%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- HK Stock Market Update · 2 days ago, 08:58 PM
Biocytogen climbs intraday after Franklin Templeton adds stake
- SCMP · Jul 15 at 11:26 PM
Mainland funds boost stakes in Hong Kong-listed biotech amid value dislocation
- Pharmaceutical Technology · Jul 8 at 02:59 AM
Biocytogen and Whitehawk partner to develop ADCs
- PUBT · Jul 7 at 07:07 AM
Biocytogen, Whitehawk Therapeutics team up on bispecific antibody-drug conjugate development
- Tip Ranks · Jun 4 at 10:09 AM
Biocytogen Calls 2026 EGM to Vote on Pay Framework and H-Share Buyback Mandate
- Tip Ranks · May 7 at 09:40 AM
Biocytogen Clarifies AGM Resolution on RMB1.5 Billion Credit Facilities and Guarantees
